SHW 10-K Analysis: The $1.17 EPS Gap Behind Sherwin-Williams' Record Claims

Sherwin-Williams, the largest paint manufacturer-retailer in North America with $23.6 billion in revenue, used the word "record" nine times in its Q4 2025 earnings release. The 10-K tells a different story: GAAP income before taxes declined 3.3% to $3,338 million, net income fell 4.2%, and the celebrated 27% free cash flow surge was nearly half capex normalization. At 31× trailing earnings, which Sherwin-Williams is the market pricing — the one in the 8-K or the one in the 10-K?

The answer matters because the two documents describe fundamentally different companies. The 8-K's adjusted EPS of $11.43 represents a 0.9% increase — enough to claim a "record." The 10-K's GAAP EPS of $10.26 represents a 2.7% decline, creating a $1.17-per-share gap between what management emphasizes and what the financials report. That $1.17-per-share gap reflects $39.1 million in new restructuring charges and $17.8 million in trademark impairment — cost centers entirely absent in FY2024 — and spans not just earnings but cash flow quality, leverage, and the very definition of growth that the current multiple implies.

SHW operates approximately 4,850 company-owned stores across three segments: Paint Stores Group (58% of revenue, 22.5% operating margin), Performance Coatings Group (29%, 13.9%), and Consumer Brands Group (13%, 16.1%). The vertically integrated model — manufacturing, distribution, and retail under one roof — creates contractor switching costs that enable industry-leading pricing power. But the 10-K reveals that this pricing power is being tested like never before, the most recent acquisition is immediately dilutive, and the balance sheet carries a zero-accrual litigation liability heading to trial.

The Record That Wasn't — GAAP vs. Adjusted Divergence

Management's "record year" narrative rests entirely on non-GAAP adjusted metrics. The 10-K reveals that every GAAP profit measure declined: income before taxes fell $113.6 million (3.3%), net income dropped 4.2% to $2,568.5 million, and GAAP EPS slid 2.7% to $10.26. The "record" applies only to adjusted EPS ($11.43, +0.9%) and net sales ($23.574 billion) — two of the five headline metrics that management highlighted in the 8-K earnings release.

"Income before income taxes: $3,338.2 million (2025) vs $3,451.8 million (2024), a decrease of $113.6 million or 3.3%."

The $1.17-per-share gap between adjusted and GAAP EPS reflects $39.1 million in restructuring charges (a new cost center — zero in FY2024), $17.8 million in trademark impairment, acquisition-related costs from the Suvinil deal, and other items that management strips out to arrive at its preferred "record" figure. Meanwhile, administrative segment costs surged $107 million (+10%) as the new global headquarters and R&D center were placed into service and interest capitalization ceased — converting what was previously a balance sheet item into a permanent SG&A headwind.

The free cash flow story reinforces the pattern. FCF surged 27% to $2,654 million — but $272 million of the $571 million improvement came from a one-time capex reduction as HQ/R&D construction wound down (capex fell from $1,070 million to $798 million). That capex normalization accounts for 48% of the entire FCF gain. Add the $206 million supplier finance program balance embedded in operating cash flow — a reverse factoring arrangement covering $986 million in annual invoices, or 41.9% of total accounts payable — and underlying "organic" FCF growth was approximately 0–5%. Management guides 2026 core capex at approximately 2% of net sales (~$471 million), which is a permanent base-rate reset, not a recurring tailwind.

The investment implication is direct: investors paying 31× trailing earnings are pricing an adjusted narrative whose GAAP foundation is eroding. Sherwin-Williams' GAAP income before taxes declined $113.6 million (3.3%) in FY2025 even as management used the word "record" nine times in the earnings release, creating a $1.17-per-share gap between adjusted and reported EPS — a gap driven by $39.1 million in restructuring charges and $17.8 million in trademark impairment that had no FY2024 precedent.

The Price of Pricing Power — Volume Elasticity at the Edge

Sherwin-Williams' approximately 4,850 company-operated stores are a genuine competitive advantage — no competitor can economically replicate this density in North America, and the contractor relationships built through proximity and technical support create real switching costs. But the 10-K reveals that this moat is being stress-tested by the most aggressive price increase in recent company history entering what management itself calls a "softer-for-longer" demand environment.

"Net sales in the Paint Stores Group increased 3.2% primarily due to selling price increases, which impacted Net sales by a mid-single digit percentage, partially offset by a low-single digit decrease in sales volume. Net sales from stores in the Paint Stores Group open for more than twelve calendar months increased 1.7% in the year over the prior year comparable period."

The math is stark: PSG total revenue grew 3.2%, but same-store sales grew just 1.7%. That means new store openings contributed roughly 47% of PSG's growth — the moat is expanding by addition, not intensification. Within same-store sales, a mid-single-digit price increase was partially offset by a low-single-digit volume decline, meaning existing stores sold fewer gallons even as prices rose.

The 7% PSG price increase effective January 2026 is 40% larger than the 5% increase that already produced volume declines. SG&A grew 3.7% against revenue growth of 2.1%, signaling negative operating leverage — costs are rising faster than the top line. Restructuring charges of $56.9 million ($39.1 million in charges plus $17.8 million in impairment) appeared for the first time in FY2025, suggesting management is already cutting costs to protect margins in a slowing volume environment.

"Although the softer-for-longer demand environment is expected to continue in 2026, we have confidence in our differentiated strategy, Success by Design, that continues to deliver innovative and productive solutions for our customers."

The store network is the asset moat; pricing power is the earnings moat. They are related but not identical. If PSG same-store sales fall below 0% in Q1 2026 — indicating that the 7% price increase is triggering volume declines larger than the revenue benefit — it signals the pricing ceiling has been reached. Sherwin-Williams' Paint Stores Group grew same-store sales just 1.7% in FY2025 despite a 5% price increase, meaning existing stores sold fewer gallons even as the company announces a 7% price hike for 2026 — the most aggressive increase in recent history entering a demand environment that management itself describes as "softer-for-longer."

The Brazil Bet and the Leverage Tightrope

Sherwin-Williams closed the $1.15 billion Suvinil acquisition in October 2025, immediately pushing total debt to $10,871 million — an increase of $983 million from the prior year. The acquisition was supposed to expand SHW's footprint in Latin American architectural coatings. The first quarter of results tells a different story.

Consumer Brands Group operating margin collapsed 290 basis points to 16.1%, and CBG gross profit actually declined $42.2 million despite revenue increasing 1.9%. Suvinil contributed $164.5 million in Q4 2025 revenue (annualizing to roughly $525 million), but the combination of lower organic volumes, unfavorable Latin American currency translation, and integration costs created a triple margin squeeze. CBG operating income dropped $80.3 million (-13.6%) year over year.

"The Consumer Brands Group's Gross profit decreased $42.2 million in 2025 compared to the same period in 2024 primarily due to lower sales volumes and unfavorable currency translation impact, partially offset by the impact from the October 2025 acquisition of Suvinil."

The tax valuation allowance for foreign operations rose 27% to $158 million, driven by "foreign jurisdictions with cumulative losses" — a signal that Suvinil's host market is generating tax losses, not profits. If CBG operating margin does not recover above 17% within two quarters, the acquisition looks structurally dilutive rather than temporarily so.

The leverage math compounds the concern. SHW returned $2,446 million to shareholders in FY2025 — 92.2% of free cash flow — while carrying $10.9 billion in debt. The reported net debt/EBITDA of 2.5× excludes $813 million in sale-leaseback financing for the HQ/R&D complex and $206 million in supplier finance balances. On a fully-loaded basis, adjusted net obligations total approximately $11.7 billion against $4.48 billion GAAP EBITDA, yielding a leverage ratio of 2.61×.

The 2027–2028 maturities ($2.4 billion) carry below-market rates that will refinance 100–150 basis points higher, adding an estimated $26–37 million in combined annual interest expense. SHW already replaced $350 million in 3.95% fixed-rate notes with commercial paper at 4.4% in January 2026 — swapping long-term certainty for short-term floating-rate exposure.

Then there is the binary risk the balance sheet does not account for at all.

"We currently have not accrued any amounts for the pending lead pigment and lead-based paint litigation because the Company does not believe it is probable that a loss will occur, or the Company believes it is not possible to estimate the range of potential losses as there is no substantive information upon which an estimate could be based."

Three Wisconsin cases are in discovery through December 2026, with trials scheduled for January through March 2027. The Ohio Supreme Court ruled in December 2024 that SHW's insurers do not have to cover lead paint abatement payments, removing the insurance backstop entirely. A New Jersey DEP lawsuit has been adjourned for rescheduling in 2026. The exposure is unquantifiable by design — zero cost until a verdict, then potentially hundreds of millions in a single quarter with no financial cushion. Sherwin-Williams carries $10.9 billion in total debt at 2.5× net leverage while returning 92% of free cash flow to shareholders, yet reserves zero dollars for pending lead paint litigation heading to Wisconsin trial in Q1 2027 with no insurance backstop.

What the Price Assumes — Valuation Reality Check

At $324 per share, Sherwin-Williams trades at 31.2× trailing GAAP EPS — a multiple that implies approximately 15% sustained annual earnings growth (at a 10% discount rate and 3% terminal growth). Management's own FY2026 guidance tells a different story: adjusted EPS of $11.50–$11.90, with a midpoint of $11.70 representing just 2.4% growth over FY2025's $11.43. Even the guidance ceiling ($11.90, or +4.1%) yields a forward adjusted P/E of 27.2×.

The gap between what the stock price assumes and what the filing supports is stark across every dimension:

The peer comparison reinforces the premium's fragility. TJX — the closest consumer-retail analog in the peer set — trades at a lower EV/EBITDA multiple with higher ROIC and no net debt:

*SBUX ROIC distorted by negative equity (negative invested capital inflates ratio).

SHW commands a 24% EV/EBITDA premium over TJX despite lower ROIC (18.8% vs. 25.9%), higher leverage ($10.7 billion net debt vs. $1.8 billion net cash), and declining GAAP earnings versus TJX's 5.1% growth. The premium is the compounder narrative — but compounders need to compound, and GAAP EPS went backward. ROIC has declined 6.2 percentage points over eight quarters, from approximately 25% to 18.8%, while the stock's multiple has held steady at 30×+.

Even constructing an optimistic scenario — demand recovery, Suvinil turns accretive within 12 months, zero litigation costs, painless refinancing — collectively yields mid-single-digit earnings growth. That is less than half what the current multiple requires. At $324 per share, Sherwin-Williams trades at 31× a GAAP EPS figure that declined 2.7%, while management's own 2026 guidance of $11.50–$11.90 adjusted EPS implies just 2.4% midpoint growth — a 12-percentage-point gap between what the price assumes and what the filing supports.

What to Watch — Five Tests for the Compounder Premium

At $324, Sherwin-Williams trades at 31× a GAAP EPS figure that declined 2.7%. The filing supports a durable store-based moat and genuine pricing power, but complicates the growth story with declining volumes, acquisition-driven margin compression, rising debt costs, and an unaccrued litigation liability. Five data points at the next earnings release will determine whether the premium holds:

1. PSG same-store sales ≥ +3% in Q1 2026 — would prove the 7% price increase is being absorbed without volume destruction, validating the pricing power moat. Below 0% means the ceiling has been reached.

2. CBG operating margin ≥ 17% — would signal Suvinil integration is accretive on schedule. Below 14% means the acquisition is structurally dilutive and the international strategy has a margin problem.

3. GAAP EPS tracking toward $11.50+ for FY2026 — would prove the GAAP-adjusted gap is closing, not widening. The $1.17 gap needs to shrink for the compounder thesis to hold on a reported-earnings basis.

4. Total debt below $10.3 billion — would signal management is prioritizing the balance sheet over buybacks. Above $10.9 billion means deleveraging has stalled while $2.4 billion in below-market maturities approach.

5. Wisconsin lead paint trial developments — any settlement, verdict, or accrual change creates a material balance sheet event. The current zero-accrual stance makes any number above zero a negative catalyst.

The 7% PSG price increase effective January 2026 is the first test: if same-store sales accelerate, the moat holds and the premium is earned. If they stall, the market is paying a record premium for a record that isn't.

Frequently Asked Questions

Is Sherwin-Williams overvalued at 31× P/E?

The 31× trailing P/E implies approximately 15% sustained annual EPS growth (at a 10% discount rate and 3% terminal growth). Management's own 2026 guidance of $11.50–$11.90 adjusted EPS implies just 0.6–4.1% growth. On a GAAP basis, EPS declined 2.7% in FY2025 to $10.26. Even using the guidance ceiling ($11.90), the forward adjusted P/E is 27.2× — a premium that exceeds TJX (30.6× P/E with 25.9% ROIC and net cash). The valuation assumes a demand recovery that the filing's "softer-for-longer" guidance explicitly contradicts.

How much did Sherwin-Williams actually earn in FY2025?

The 8-K earnings release emphasizes adjusted EPS of $11.43 (+0.9%), calling it "record." The 10-K reports GAAP EPS of $10.26 (-2.7%) and net income of $2,568.5 million (-4.2%). Income before taxes declined $113.6 million (-3.3%) to $3,338.2 million. The $1.17/share gap reflects restructuring charges ($39.1 million), trademark impairment ($17.8 million), acquisition-related costs, and other items. The "record" claim holds only on the adjusted side.

What is SHW's lead paint litigation exposure?

Sherwin-Williams carries zero accrual for pending lead paint litigation, stating it is "not probable that a loss will occur." In December 2024, the Ohio Supreme Court ruled that SHW's insurers do not have to cover lead paint abatement payments, removing the insurance backstop. Three active Wisconsin cases are in discovery through December 2026 with trials scheduled for January–March 2027. A New Jersey DEP lawsuit has been adjourned for rescheduling in 2026. This is a binary risk: zero cost until a verdict, then potentially hundreds of millions in a single quarter.

Is Sherwin-Williams' 27% FCF growth sustainable?

The 27% FCF increase ($2.083 billion to $2.654 billion) was primarily driven by a $272 million capex reduction as HQ/R&D construction wound down ($1.07 billion to $798 million), representing 48% of the FCF improvement. Additionally, $206 million in reported OCF comes from a supplier finance program that could be reclassified to financing activity. Stripping out the capex normalization and supplier finance effect, underlying FCF growth was approximately 0–5%. Management guides 2026 core capex at approximately 2% of net sales (~$471 million), which is a permanent base-rate reset, not a recurring improvement.

How is the Suvinil acquisition performing?

Early signals are mixed to negative. Suvinil contributed $164.5 million in revenue in Q4 2025, annualizing to approximately $525 million. However, Consumer Brands Group operating margin collapsed 290 basis points to 16.1%, and CBG gross profit actually declined $42.2 million despite revenue rising 1.9%. Tax valuation allowances for foreign operations rose 27% to $158 million. If CBG margin does not recover to 17%+ within two quarters, it signals a structural problem rather than integration drag.

What is Sherwin-Williams' pricing power limit?

SHW implemented a 5% PSG price increase in January 2025 and announced a 7% increase for January 2026 — the most aggressive in recent history. In FY2025, pricing drove mid-single-digit revenue gains while volume declined low-single-digits. Same-store sales grew just 1.7%, meaning new stores contributed roughly half of PSG's 3.2% total growth. The 7% hike enters a "softer-for-longer" demand environment. If PSG same-store sales fall below 0% in Q1 2026, it signals the pricing ceiling has been reached. SHW's moat thesis depends on contractor switching costs being high enough to absorb annual price increases — the 7% increase tests this assumption more aggressively than ever.

How leveraged is Sherwin-Williams?

Total debt is $10.871 billion (up $983 million from 2024), with net debt/EBITDA of 2.5× by pipeline calculation and 2.38× using GAAP EBITDA. However, these figures exclude $813 million in sale-leaseback financing obligations for the HQ/R&D complex and $206 million in supplier finance program balances. On a fully-loaded basis, adjusted net obligations total approximately $11.7 billion against $4.48 billion GAAP EBITDA, yielding 2.61× leverage. The debt maturity schedule shows $1.5 billion due 2027 and $900 million due 2028, all carrying below-market rates (~3.45%) that will refinance at 4.5–5%, adding an estimated $26–37 million in combined annual interest expense.

What does SHW's 2026 guidance imply about growth?

Management guides FY2026 GAAP EPS of $10.70–$11.10 (midpoint $10.90, +6.2% vs. FY2025 GAAP EPS of $10.26) and adjusted EPS of $11.50–$11.90 (midpoint $11.70, +2.4% vs. $11.43). At $324/share, even the guidance ceiling ($11.90 adj EPS) yields a forward adjusted P/E of 27.2×. The guidance includes $0.80/share in acquisition-related amortization and assumes low-single-digit raw material cost increases offset by pricing and simplification efforts. It does not assume a demand recovery — the "softer-for-longer" outlook is explicitly extended into 2026.

Does Sherwin-Williams' store network provide a durable moat?

The approximately 4,853 company-operated stores are a genuine competitive advantage, generating about $2.80 million per store in PSG revenue. No competitor can economically replicate this density in North America. The moat operates through contractor relationships: professional painters prefer proximity, technical support, and account terms that deepen with store density. SHW targets 80–100 net new stores annually, maintaining approximately 2% network growth. However, the moat's economic value depends on pricing power — if volume declines accelerate beyond low-single-digits, the per-store economics weaken. The store network is an asset moat; pricing power is the earnings moat — they are related but not identical.

What is SHW's supplier finance program and why does it matter?

SHW operates a reverse factoring program where third-party banks pay SHW's suppliers early, and SHW pays the banks later. The outstanding balance at year-end 2025 was $206.1 million (2024: $215.7 million), with $986.3 million in invoices flowing through the program during the year — representing 41.9% of total accounts payable. The balance is currently classified within accounts payable (operating activity). If accounting standards change to require reclassification as financing activity, it would reduce reported OCF by $206 million (6% of the $3.452 billion total). The scale relative to SHW's accounts payable warrants monitoring, even though reverse factoring programs are common among large manufacturers.

What would cause the thesis to break?

Three conditions, if met simultaneously, invalidate the thesis: (1) Q1–Q2 2026 PSG same-store sales growth accelerates to 3%+ despite the 7% price increase — proving volume elasticity is not materializing and the pricing ceiling is higher than feared; (2) CBG operating margin recovers above 17% within two quarters — proving Suvinil is rapidly accretive and the international strategy is working; (3) FY2026 GAAP EPS tracks toward $11.50+ (above adj guidance midpoint) — proving the GAAP-adjusted gap is closing, not widening. Any single condition met weakens the thesis; all three met together invalidate it.

How does SHW's Firetex product liability differ from lead paint risk?

The Firetex situation is newer and narrower. A third-party certification provider changed its listing for Firetex FX9502, an intumescent fire protection coating. The 10-K reveals the investigation has expanded beyond FX9502 to "certain other Firetex intumescent products" and to the Firetex Design Estimator software, which recommended dry film thicknesses exceeding published maximums. A competitor (Carboline) filed an amended false advertising complaint in November 2025. Unlike lead paint, Firetex is a quantifiable product liability issue with identifiable affected products and buildings. The financial exposure is likely smaller than lead paint but more near-term and actionable — remediation costs, customer claims, and potential settlement with Carboline.

Methodology

Data Sources

This analysis relies on four primary sources: (1) The Sherwin-Williams Company's FY2025 10-K filed February 19, 2026, as the primary source for all GAAP financials, segment data, risk factors, and footnotes; (2) SHW's Q4 2025 8-K earnings release (filed January 29, 2026) for adjusted metrics, management commentary, and FY2026 guidance; (3) MetricDuck's automated financial data pipeline for historical financial metrics, valuation multiples, and peer comparison data sourced from SEC XBRL filings; and (4) peer company filings and pipeline data for TJX, CVS, DIS, and SBUX.

Filing sections analyzed include: risk_factors, mda_results_operations, mda_liquidity, footnote_segment, footnote_debt, footnote_accounting_policies, footnote_commitments, and mda_critical_accounting.

Limitations

• Suvinil standalone economics unknown. Only one quarter of Suvinil contribution ($164.5 million revenue). Cannot isolate Suvinil's operating margin within the Consumer Brands Group segment.
• Lead paint exposure is unquantifiable. Zero accrual means zero disclosed exposure. The range of outcomes spans $0 to multi-billions. Any numerical estimate would be speculation.
• Peer set is non-operational. TJX, CVS, DIS, and SBUX are consumer/retail analogs for capital allocation and valuation comparison, not direct paint/coatings competitors (PPG, RPM, AXTA would be more operationally comparable).
• Valuation analysis is not a price target. The "Valuation Reality Check" identifies what the current price implies using a DCF framework (10% discount rate, 3% terminal growth). It is not a recommendation.
• Pipeline data timing varies. SHW and CVS data as of December 2025; TJX as of November 2025; SBUX as of September 2025. Minor comparability gaps exist.
• "Organic" FCF is an approximation. The 0–5% organic FCF growth estimate adjusts for capex normalization and supplier finance balance, but cannot isolate all non-recurring working capital movements.

Disclaimer:

This analysis is for informational purposes only and does not constitute investment advice. The author does not hold positions in SHW, TJX, CVS, DIS, or SBUX. Past performance and current metrics do not guarantee future results. All data is derived from public SEC filings and may contain errors or omissions from the automated extraction process.